420 related articles for article (PubMed ID: 25057039)
1. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
Eilertsen GØ; Nossent JC
Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
[TBL] [Abstract][Full Text] [Related]
2. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
3. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
[TBL] [Abstract][Full Text] [Related]
4. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
[TBL] [Abstract][Full Text] [Related]
6. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
[TBL] [Abstract][Full Text] [Related]
7. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
George-Chandy A; Trysberg E; Eriksson K
Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
Scand J Rheumatol; 2011; 40(5):363-72. PubMed ID: 21585290
[TBL] [Abstract][Full Text] [Related]
9. Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease.
Xin G; Cui Z; Su Y; Xu LX; Zhao MH; Li KS
Nephrology (Carlton); 2013 Mar; 18(3):209-14. PubMed ID: 23317407
[TBL] [Abstract][Full Text] [Related]
10. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
Becker-Merok A; Nikolaisen C; Nossent HC
Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
[TBL] [Abstract][Full Text] [Related]
11. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus.
Chu VT; Enghard P; Schürer S; Steinhauser G; Rudolph B; Riemekasten G; Berek C
Arthritis Rheum; 2009 Jul; 60(7):2083-93. PubMed ID: 19565488
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus.
Minowa K; Amano H; Nakano S; Ando S; Watanabe T; Nakiri Y; Amano E; Tokano Y; Morimoto S; Takasaki Y
Autoimmunity; 2011 Aug; 44(5):357-62. PubMed ID: 21320038
[TBL] [Abstract][Full Text] [Related]
14. [BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity].
Vadacca M; Margiotta D; Sambataro D; Buzzulini F; Lo Vullo M; Rigon A; Afeltra A
Reumatismo; 2010; 62(4):259-65. PubMed ID: 21253619
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
[TBL] [Abstract][Full Text] [Related]
16. Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis.
Gümüş P; Nizam N; Lappin DF; Buduneli N
J Periodontol; 2014 Feb; 85(2):270-80. PubMed ID: 23701482
[TBL] [Abstract][Full Text] [Related]
17. Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis.
Phatak S; Chaurasia S; Mishra SK; Gupta R; Agrawal V; Aggarwal A; Misra R
Clin Exp Immunol; 2017 Mar; 187(3):376-382. PubMed ID: 27804111
[TBL] [Abstract][Full Text] [Related]
18. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Hoi AY; Slavin L; Godsell JD; Kitching AR; Harris J; Nelson CL; Jenkins AJ; Chrysostomou A; Hibbs ML; Kerr PG; Rischmueller M; Mackay F; Morand EF
Lupus; 2018 Nov; 27(13):2029-2040. PubMed ID: 30301439
[TBL] [Abstract][Full Text] [Related]
19. The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosus.
Sari S; Cinar S; Yalcinkaya Y; Artim-Esen B; Ozluk Y; Gul A; Ocal L; Deniz G; Inanc M
Lupus; 2022 Apr; 31(5):555-564. PubMed ID: 35249405
[TBL] [Abstract][Full Text] [Related]
20. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
